APVONasdaqPharmaceutical PreparationsFiscal year ends December 31
Aptevo Therapeutics Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.60−0.02 (-1.23%)
Close on Oct 19, 2026
- Market cap
- $1.91M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Aptevo Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 14, 2026 | Oct 14, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 24, 2026 | Sep 24, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 22, 2026 | Sep 23, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 3, 2026 | Sep 3, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 22, 2026 | Aug 31, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 21, 2026 | Aug 21, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 13, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 31, 2026 | Jul 31, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 27, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 29, 2026 | Jun 30, 2026 | SEC EDGAR |
| Current report | 8-K | May 25, 2026 | May 27, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 13, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 26, 2026 | Mar 26, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 10, 2026 | Mar 11, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 18, 2026 | Feb 19, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2026 | Feb 3, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jan 23, 2026 | Jan 26, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 29, 2025 | Dec 29, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 9, 2025 | Dec 9, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 30, 2025 | Oct 30, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 16, 2025 | Sep 16, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 4, 2025 | Sep 4, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2025 | Aug 11, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2025 | Jul 24, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jul 24, 2025 | Jul 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 1, 2025 | Jul 1, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jun 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 23, 2025 | Jun 23, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 20, 2025 | Jun 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 18, 2025 | Jun 20, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 16, 2025 | Jun 17, 2025 | SEC EDGAR |